ArticleInternational journal of general medicine2025
Sigma-1 Receptor Rescues Autophagy Through AMPK/mTOR Signaling Pathway in Sepsis-Induced Acute Kidney Injury.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Sigma-1 receptor protects against renal ischemia-reperfusion injury by enhancing mitophagy via Rac1 regulation.Renal failure · 2026Article
- Article
- The Role of Sigmar1 in Autophagy Regulation and Disease Therapy.International journal of molecular sciences · 2026Review
- Crosstalk of regulated cell death pathways in sepsis-associated acute kidney injury: implications for therapy.Frontiers in cell and developmental biology · 2026Review
- Autophagy-senescence interplay in kidney disease: mechanistic insights and therapeutic potential.Molecular biology reports · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to investigate the effects of σ-1R on autophagy in sepsis-AKI and its potential involvement in the AMPK/mTOR signaling pathway. Methods: The serum samples from patients were used to diagnose sepsis and sepsis-AKI using double-blind and randomized method and to quantify σ-1R and inflammatory cytokines using enzyme-linked immunosorbent assays. HK-2 cells induced by lipopolysaccharide (LPS) were employed as an in vitro model of sepsis-AKI. To evaluate the function of σ-1R in sepsis-AKI, siRNA and an overexpression plasmid targeting σ-1R were used. σ-1R and autophagy marker expressions were analyzed using quantitative real-time polymerase chain reaction and Western blot assays. Cell proliferation was evaluated using CCK-8 and EdU assays, and cell apoptosis was detected using flow cytometry and TUNEL staining assays. Phosphorylated proteins were detected in the AMPK/mTOR signaling pathway. Results: In sepsis and sepsis-AKI, σ-1R levels were reduced, whereas the levels of interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α (TNF-α) increased. σ-1R promoted the proliferation of LPS-induced HK-2 cells while inhibiting apoptosis. Moreover, σ-1R enhanced autophagy, as evidenced by the upregulation of autophagy biomarkers LC3-II/LC3-I and Beclin 1. Furthermore, σ-1R promoted the phosphorylation of AMPK and ULK1 while inhibiting mTOR. Conclusion: σ-1R utilizes the AMPK/mTOR signaling pathway to enhance autophagy in sepsis-AKI, indicating that σ-1R may serve as a promising target for sepsis-AKI diagnosis and therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.